Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Grunenthal's 2013 immunology sales performance.

Survival strategy

In November Gedeon Richter acquired the oral contraceptive range from Grunenthal for $329m and during the year there were product acquisitions by other mid-sized companies, such as Meda Pharma buying ... Immunotherapy company acquisition.  . 428.

Endo to buy Penwest

The new formulation, which was developed in partnership with the global pharma firm Grunenthal, is designed to reduce the potential for abuse and misuse.

Studies prove poverty link to poor health

The study, using data extracted from the Health Survey for England 2005, was funded by Grunenthal and presented at the British Pain Society Annual Scientific Meeting on Thursday, April 15.

The key to success

In short, the authoritative industry professionals saw KOL management becoming, as Norbert van Rooij of Germany's Grünenthal, put it: "Our number one USP".

People, September, 2005

He has over 30 years' experience in the pharmaceutical industry. Jon Daly has been appointed marketing manager of Grünenthal UK and Ireland.

[ Previous 5 results ] 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts


Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...
2019: CRISPR and therapeutic gene editing comes of age
Can gene-editing deliver safe and effective therapeutics for patients with intractable diseases?...